Exact Sciences and Pfizer Extend and Amend Cologuard(R) Promotion Agreement

Successful collaboration will continue to support Cologuard adoption through 2022

MADISON, Wis. and NEW YORK, Oct. 7, 2020 -- (Healthcare Sales & Marketing Network) -- Exact Sciences Corp. (Nasdaq: EXAS) and Pfizer Inc. (NYSE: PFE) today announced an e... Diagnostics, Oncology Exact Sciences, Pfizer, Cologuard, colorectal cancer

Source: HSMN NewsFeed - October 7, 2020 Category: Pharmaceuticals Source Type: news